Establishment of the collection, storage and preservation methods and their influence on stability of human salivary exosome
Keywords:
salivary exosome, human saliva, Nanoparticle-Tracking Analysis, exosome storage, protease inhibitorAbstract
The functions displayed by exosomes derived from saliva and other body fluids have been established. This paper studied the stability of human salivary exosome beginning from the collection mode, storage, and its preservation methods. Unstimulated saliva samples were collected from healthy subjects. Protease inhibitor was added into each samples and stored under different temperatures and at varying periods of time. The exosomes were isolated by ultracentrifugation and confirmed by using Western Blot. Exosome morphology was inspected by Scanning Electron Microscope (SEM) and the protein concentration was determined using the Protein (Bradford) Assay. The exosome particle size distribution and concentration were calculated using Nanoparticle Tracking Analysis (NTA). The protein assay showed no significant differences in the exosome protein concentration values for all conditions. Western Blot analysis also showed no differences in the presence of exosome and all the samples were positive for protein CD63. SEM analysis showed the fine shape of exosome which is round, in vesicle form with the size ranging between 10 nm and 100 nm. NTA determined the individual mean and the clumping exosome size was 203 nm. Human salivary exosomes remained intact in the absence of protease inhibitor and in different storage temperatures.Â
References
Shahidan WNS. MicroRNA analysis in saliva [Doctoral (Academic) thesis]. Japan: The University of Tokushima Graduate School; 2011.
Schenkels LCPM, Veerman ECI, Amerongen AVN. Biochemical composition of human saliva in relation to other mucosal fluids. Critical Reviews in Oral Biology and Medicine; 1995;6:pp. 161-75.
Ogawa Y, Miura Y, Harazono A, et al. Proteomic analysis of two types of exosomes in human whole saliva. Biological and Pharmaceutical Bulletin; 2011;34(1):pp. 13-23.
Keller S, Sanderson MP, Stoeck A, et al. Exosomes: From biogenesis and secretion to biological function. Immunology Letters; 2006;107(2):pp. 103-8.
Sharma S, Rasool HI, Palanisamy V, et al. Structural-mechanical characterization of nano-particles-exosomes in human saliva, using correlative AFM, FESEM and force spectroscopy. ACS Nano; 2010;40:pp. 1-11.
Palanisamy V, Sharma S, Deshpande A, et al. Nanostructural and Transcriptomic Analyses of Human Saliva Derived Exosome. PLoS ONE; 2010;5 (1):pp. 1-11. Epub 5 January 2010.
Zhou H, Yuen PST, Pisitkun T, et al. Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery. Kidney International; 2006;69(9):pp. 1461-76.
Li P, Kaslan M, Lee SH, et al. Progress in Exosome Isolation Techniques. Theranostics 2017;7(3):pp. 789-804.
Lässer C, Eldh M, Lötvall J. Isolation and characterization of RNA-containing exosomes.
Journal of Visualized Experiments; 2012(59):pp.
Greening DW, Xu R, Ji H, et al. A Protocol for Exosome Isolation and Characterization: Evaluation of Ultracentrifugation, Density-Gradient Separation, and Immunoaffinity Capture Methods. In: Posch A, editor. Proteomic Profiling: Methods and Protocols. New York, NY: Springer New York; 2015. p. 179-209.
Théry C, Amigorena S, Raposo G, et al. Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids. Current Protocols in Cell Biology: John Wiley & Sons, Inc.; 2006.
Cheruvanky A, Zhou H, Pisitkun T, et al. Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator. American Journal of Physiology - Renal Physiology; 2007;292(5):pp. F1657-F61.
Wang K, Zhang S, Weber J, et al. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Research; 2010;38(20):pp. 7248-59.
Zeringer E, Barta T, Li M, et al. Strategies for Isolation of Exosomes. Cold Spring Harbor Protocols; 2015:pp. 319-24.
Zarovni N, Corrado A, Guazzi P, et al. Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches. Methods; 2015;87:pp. 46-58.
Lee K, Shao H, Weissleder R, et al. Acoustic Purification of Extracellular Microvesicles. ACS Nano; 2015;9(3):pp. 2321-7.
He M, Crow J, Roth M, et al. Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology Lab on a Chip; 2014;14(19):pp. 3773-80.
Wang Z, Wu H-j, Fine D, et al. Ciliated micropillars for the microfluidic-based isolation of nanoscale lipid vesicles. Lab on a chip; 2013;13(15):pp. 2879-82.
Malloy A. Count, size and visualize nanoparticles. Materials Today; 2011;14(4):pp. 170-3.
Heintze U, Birkhed D, Björn H. Secretion Rate and Buffer Effect of Resting and Stimulated Whole Saliva as a Function of Age and Sex. Swedish Dental Journal; 1983;7(6):pp. 227-38.
Ekström J, Khosravani N, Castagnola M, et al. Saliva and the Control of Its Secretion. In: Ekberg O, editor. Dysphagia: Diagnosis and Treatment. Berlin, Heidelberg: Springer Berlin Heidelberg; 2012. p. 19-47.
Lagerlof F, Dawes C. The Volume of Saliva in the Mouth Before and After Swallowing. Journal of Dental Research; 1984;63(5):pp. 618-21.
DÃaz-MartÃn V, Manzano-Román R, Valero L, et al. An insight into the proteome of the saliva of the argasid tick Ornithodoros moubata reveals important differences in saliva protein composition between the sexes. Journal of Proteomics; 2013;80:pp. 216-35.
Yamada T, Inoshima Y, Matsuda T, et al. Comparison of methods for isolating exosome from bovine milk.
Journal of Veterinary Medical Science; 2012;74(11):pp. 1523-5.
Wu Y, Deng W, Klinke DJ. Exosomes: Improved methods to characterize their morphology, RNA content, and surface protein biomarkers. Analyst; 2015;140:pp. 6631-42.
Schneider A, Simons M. Exosomes: Vesicular carriers for intercellular communication in neurodegenerative disorders. Cell Tissue Research; 2013;352:pp. 33-47.
Hood JL, Scott MJ, Wickline SA. Maximizing exosome colloidal stability following electroporation. Analytical Biochemistry; 2014;448:pp. 41-9.
Ge Q, Zhou Y, Lu J, et al. miRNA in plasma exosome is stable under different storage conditions. Molecules; 2014;19(2):pp. 1568-75.
Buchner J, Walter S. Molecular chaperones–cellular machines for protein folding. Angewandte Chemie; 2002;41(7):pp. 1098-113.
Keller S, Ridinger J, Rupp A-K, et al. Body fluid derived exosomes as a novel template for clinical diagnostics. Journal of Translational Medicine; 2011;9(1):pp. 86.
Cheng Y, Zeng Q, Han Q, et al. Effect of pH, temperature and freezing-thawing on quantity changes and cellular uptake of exosomes. Protein & Cell; 2018:pp.
Lee M, Ban J, Im W, et al. Influence of storage condition on exosome recovery. Biotechnology and Bioprocess Engineering; 2016;21:pp. 299-304.
Simpson RJ, Lim JWE, Moritz RL, et al. Exosomes: proteomic insights and diagnostic potential. Expert Reviews Proteomics; 2009;6(3):pp. 267-83.
Lai RC, Yeo RWY, Tan KH, et al. Exosomes for drug delivery - A novel application for the mesenchymal stem cell. Biotechnology Advances; 2012;31:pp. 534-51.
Downloads
Additional Files
Published
Issue
Section
License
JBCS Publication Ethics
JBCS is committed to ensure the publication process follows specific academic ethics. Hence, Authors, Reviewers and Editors are required to conform to standards of ethical guidelines.
Authors
Authors should discuss objectively the significance of research work, technical detail and relevant references to enable others to replicate the experiments. JBCS do not accept fraudulent or inaccurate statements that may constitute towards unethical conduct.
Authors should ensure the originality of their works. In cases where the work and/or words of others have been used, appropriate acknowledgements should be made. JBCS do not accept plagiarism in all forms that constitute towards unethical publishing of an article.
This includes simultaneous submission of the same manuscript to more than one journal. Corresponding author is responsible for the full consensus of all co-authors in approving the final version of the paper and its submission for publication.
Reviewers
Reviewers of JBCS treat manuscripts received for review as confidential documents. Therefore, Reviewers must ensure the confidentiality and should not use privileged information and/or ideas obtained through peer review for personal advantage.
Reviews should be conducted based on academic merit and observations should be formulated clearly with supporting arguments. In cases where selected Reviewer feels unqualified to review a manuscript, Reviewer should notify the editor and excuse himself from the review process in TWO (2) weeks time from the review offer is made.
In any reasonable circumstances, Reviewers should not consider to evaluate manuscripts if they have conflicts of interest (i.e: competitive, collaborative and/or other connections with any of the authors, companies, or institutions affiliated to the papers).
Editors
Editors should evaluate manuscripts exclusively based on their academic merit. JBCS strictly do not allow editors to use unpublished information of authors without the written consent of the author. Editors are required to take appropriate responsive actions if ethical complaints have been presented concerning a submitted manuscript or published paper.
CONFLICT OF INTEREST
Journal of Biomedical and Clinical Sciences requires authors to declare all competing interests in relation to their work. All submitted manuscripts must include a ‘competing interests section at the end of the manuscript listing all competing interests (financial and non-financial). Where authors have no competing interests, the statement should read ,The authors have declared that no competing interests exist. Editors may ask for further information relating to competing interests.
Editors and reviewers are also required to declare any competing interests and will be excluded from the peer review process if a competing interest exists. Competing interests may be financial or non-financial. A competing interest exists when the authors interpretation of data or presentation of information may be influenced by their personal or financial relationship with other people or organizations. Authors should disclose any financial competing interests but also any non-financial competing interests that may cause them embarrassment if they were to become public after the publication of the article.
HUMAN AND ANIMAL RIGHTS
All research must have been carried out within an appropriate ethical framework. If there is suspicion that work has not taken place within an appropriate ethical framework, Editors will follow the Misconduct policy and may reject the manuscript, and/or contact the author(s) institution or ethics committee. On rare occasions, if the Editor has serious concerns about the ethics of a study, the manuscript may be rejected on ethical grounds, even if approval from an ethics committee has been obtained.
Research involving human subjects, human material, or human data, must have been performed in accordance with the Declaration of Helsinki and must have been approved by an appropriate ethics committee. A statement detailing this, including the name of the ethics committee and the reference number where appropriate, must appear in all manuscripts reporting such research. Further information and documentation to support this should be made available to Editors on request.
Experimental research on vertebrates or any regulated invertebrates must comply with institutional, national, or international guidelines, and where available should have been approved by an appropriate ethics committee. The Basel Declaration outlines fundamental principles to adhere to when conducting research in animals and the International Council for Laboratory Animal Science (ICLAS) has also published ethical guidelines.
A statement detailing compliance with relevant guidelines (e.g. the revised Animals (Scientific Procedures) Act 1986 in the UK and Directive 2010/63/EU in Europe) and/or ethical approval (including the name of the ethics committee and the reference number where appropriate) must be included in the manuscript. The Editor will take account of animal welfare issues and reserves the right to reject a manuscript, especially if the research involves protocols that are inconsistent with commonly accepted norms of animal research. In rare cases, Editors may contact the ethics committee for further information.
INFORMED CONSENT
For all research involving human subjects, informed consent to participate in the study should be obtained from participants (or their parent or guardian in the case of children under 16) and a statement to this effect should appear in the manuscript, this includes to all manuscripts that include details, images, or videos relating to individual participants.
DATA SHARING POLICY
JBCS strongly encourages that all datasets on which the conclusions of the paper rely should be available to readers. We encourage authors to ensure that their datasets are either deposited in publicly available repositories (where available and appropriate) or presented in the main manuscript or additional supporting files, in machine-readable format (such as spreadsheets rather than PDFs) whenever possible
Authors who do not wish to share their data must state that data will not be shared, and give the reason.
COPYRIGHT NOTICE
The JBCS retains the copyright of published manuscripts under the terms of the Copyright Transfer Agreement. However, the journal permits unrestricted use, distribution, and reproduction in any medium, provided permission to reuse, distribute and reproduce is obtained from the Journal's Editor and the original work is properly cited.
While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
Copyright (c) 2023 Journal of Biomedical and Clinical Sciences (JBCS)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
